Adam J Waxman Selected Research

Immunotherapy

1/2024	T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
3/2023	Progressive multifocal leukoencephalopathy in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam J Waxman Research Topics

Disease

6	Multiple Myeloma 05/2024 - 01/2016
3	Immunoglobulin Light-chain Amyloidosis 05/2024 - 01/2021
3	Neoplasms (Cancer) 05/2024 - 01/2024
2	Leukemia 05/2024 - 01/2024
2	Monoclonal Gammopathy of Undetermined Significance 05/2024 - 01/2024
2	Heart Failure 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024
1	Residual Neoplasm 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Amyloidosis 01/2021
1	Diarrhea 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Thrombotic Microangiopathies 01/2016

Drug/Important Bio-Agent (IBA)

4	Bortezomib (Velcade)FDA Link 05/2024 - 01/2016
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 01/2023
2	Busulfan (Busulfex)FDA Link 05/2024 - 01/2024
2	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2023
2	carfilzomibIBA 03/2018 - 01/2016
1	pomalidomideIBA 01/2023
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	daratumumabIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	AnthracyclinesIBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Proteasome InhibitorsIBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2019
2	Immunotherapy 01/2024 - 03/2023
1	Aftercare (After-Treatment) 03/2023